Ranbaxy Laboratories, India’s biggest drug maker by revenue, said it expects sales to increase by at least 10 per cent in 2012 as it takes advantage of expiring drug patents in the United States, its biggest market. Ranbaxy, which launched a generic version of cholesterol drug Lipitor in the US market in December, reported a fourth-quarter loss equivalent to $606 million. Sales, however, soared 79.2 per cent to $759.37 million in the quarter to Dec.31 from a year earlier, and were up 16.6 per cent at $2.02 billion for the full year.
GMT 12:09 2018 Monday ,26 November
Black Friday less wild as more Americans turn to online dealsGMT 15:07 2018 Sunday ,18 November
Refugee host countries discuss UNRWA's financial crisisGMT 17:22 2018 Wednesday ,31 October
Russia climbed to 31st place in Doing Business-2019 ratingGMT 16:53 2018 Wednesday ,17 October
"Putin" We need for collective restoration of Syria's economyGMT 14:02 2018 Friday ,12 October
Govt to announce incentives package for Overseas PakistanisGMT 18:26 2018 Saturday ,06 October
Dubai attracts Dh17.7 billion in foreign direct investmentGMT 09:02 2018 Friday ,21 September
Economy of Georgia demonstrates "strong signs of recovery"GMT 09:03 2018 Wednesday ,24 January
German investor confidence surges in JanuaryMaintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2021 ©
Send your comments
Your comment as a visitor